Complications of Therapeutic Plasmapheresis in Patients with Neurologic Diseases at A Tertiary Care Hospital

Objective: To determine the complications of therapeutic plasmapheresis in patients with neurologicaldiseases at a tertiary care hospital.Study Design: Cross-sectional study.Place and Duration of Study: The study was carried out at Department of Neurology, Pak Emirates MilitaryHospital (PEMH) Rawalpindi, Pakistan from August 2021 to July 2022.Methods: This study was carried out on patients diagnosed with various neurologic diseases where therapeuticplasmapheresis was performed which involves the replacement of patient plasma with donor plasma. A totalof 680 therapeutic plasmapheresis treatments were performed on patients with a variety of neurologicdiseases. Ppatients with hemodynamic instability, active sepsis, coagulopathy, and known allergies to freshfrozen plasma were excluded from the study. Data was recorded from consenting patients on a pre-designedproforma recording various parameters.Results: Among 680 treatments,76.2% were carried out in males and 23.8% in females.Guillain Barre Syndrome (42.06%) was the most common disease followed by chronic inflammatorydemyelinating polyneuropathy (13.82%), neuromyelitis optical spectrum disorders (10.29%), and myastheniagravis (7.94%) being the most common ones. In total 157 (23%) adverse events were noted, with fever (2.9%),pruritis (2.8%), urticaria and mild hypotension (2.5% each), tachycardia (2.2%), and DVT (1.3%) beingcommonly encountered complications. Anaphylaxis was recorded in 0.1%. The majority of the reactions weremild 118 (17.3%), some moderate 21 (3%), and few were severe 11 (1.6%). Serious, life-threatening events wereseen in 0.1% and none had a fatal outcome. Prophylactic use of calcium resulted in lower electrolyte imbalancerelatedcomplications.Conclusion: Therapeutic plasmapheresis is a safer treatment option for various neurologic diseases whenperformed by trained staff. How to cite this: Ahmed N, Ahmad I, Siddiqi FA, Nawaz KH, Liaqat J, Ahmad F. Complications of Therapeutic Plasmapheresis in Patients with Neurologic Diseases at A Tertiary Care Hospital. Life and Science. 2024; 5(2): 259-265. doi: http://doi.org/10.37185/LnS.1.1.538